NeuPath Health Inc (NPTH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, NeuPath Health Inc (NPTH) has a cash flow conversion efficiency ratio of -0.010x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-203.00K ≈ $-146.85K USD) by net assets (CA$21.32 Million ≈ $15.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see NeuPath Health Inc (NPTH) total market value for the company's overall valuation and market capitalisation.
NeuPath Health Inc - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how NeuPath Health Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
NeuPath Health Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NeuPath Health Inc ranked by their cash flow conversion efficiency. Explore NPTH cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mohenz.Co.Ltd
KQ:006920
|
0.017x |
|
CyberOne Co. Ltd.
KQ:356890
|
-0.015x |
|
Quickfee Ltd
AU:QFE
|
-0.564x |
|
Parkway Corporate Ltd
AU:PWN
|
-0.011x |
|
Environmental Group Ltd (the)
AU:EGL
|
-0.067x |
|
Blossom M&C Co. Ltd
KQ:263920
|
-0.023x |
|
Dyandra Media International PT
JK:DYAN
|
-0.037x |
|
Country Club Hospitality & Holidays Limited
NSE:CCHHL
|
0.014x |
Annual Cash Flow Conversion Efficiency for NeuPath Health Inc (2019–2025)
The table below shows the annual cash flow conversion efficiency of NeuPath Health Inc from 2019 to 2025. View NeuPath Health Inc stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CA$20.95 Million ≈ $15.16 Million |
CA$4.00 Million ≈ $2.90 Million |
0.191x | +57.07% |
| 2024-12-31 | CA$21.43 Million ≈ $15.50 Million |
CA$2.61 Million ≈ $1.89 Million |
0.122x | -12.33% |
| 2023-12-31 | CA$21.84 Million ≈ $15.80 Million |
CA$3.03 Million ≈ $2.19 Million |
0.139x | +307.07% |
| 2022-12-31 | CA$21.65 Million ≈ $15.66 Million |
CA$738.00K ≈ $533.86K |
0.034x | -54.12% |
| 2021-12-31 | CA$25.83 Million ≈ $18.69 Million |
CA$1.92 Million ≈ $1.39 Million |
0.074x | +417.69% |
| 2020-12-31 | CA$27.62 Million ≈ $19.98 Million |
CA$-646.00K ≈ $-467.31K |
-0.023x | +76.83% |
| 2019-12-31 | CA$9.77 Million ≈ $7.07 Million |
CA$-986.00K ≈ $-713.26K |
-0.101x | -- |
About NeuPath Health Inc
NeuPath Health Inc. provides chronic pain management services in Canada. It operates a network of medical clinics in Ontario and Alberta that offer assessments and rehabilitation services to patients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions. The company also provides workplace health services and independent medical assessments to employers and di… Read more